Fludrocortisone
Fludrocortisone is a pharmaceutical drug with 23 clinical trials. Currently 1 active trials ongoing. Historical success rate of 86.7%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
8
Early Stage
5
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
72.2%
13 of 18 finished
27.8%
5 ended early
1
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects
Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
Clinical Trials (23)
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)
Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects
Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
Stress & Social Cognition in BPD (part 2)
A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)
Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients
Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension
Androgen Reduction in Congenital Adrenal Hyperplasia
The Role of Minerelocorticoid Receptor on Modulating Aldosterone Production
Orthostatic Dysregulation and Associated Gastrointestinal Dysfunction in Parkinson's Disease -Treatment
Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression
Fludrocortisone for Sudden Hearing Loss
Mineralocorticoid Receptor in the Treatment of Severe Depression
Effects of Mineralocorticoid Receptor Stimulation on Cognition
Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
Fludrocortisone and Information Processing in Healthy Volunteers
Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock
Effects of Fludrocortisone and Hydrocortisone in Healthy Volunteers With Aldosterone Induced Suppression
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 23